Is this you? Create Your Porfile
Avatar

Joachim Huetter

Bayer Corporation

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Joachim Huetter is active.

Explore More

Publication

Featured researches published by Joachim Huetter.

BMC Pharmacology | 2007

The use of PDE5 inhibitors in the treatment of benign prostate hyperplasia and lower urinary tract symptoms: preclinical evidences

Peter Sandner; Hanna Tinel; Beatrix Stelte-Ludwig; Erwin Bischoff; Joachim Huetter

Material-methods The mRNA expression of PDE5 was determined in rat tissues of the lower urinary tract. To test the functional relevance of the PDE5 expression, sildenafil, vardenafil, and tadalafil were tested on pre-contracted isolated rat bladder, prostate and urethra strips. The in vivo efficacy was tested in a partial bladder outlet obstruction (BOO) model after acute and chronic treatment.

Analytical Biochemistry | 2004

A nonradioactive 96-well plate assay for the detection of hypoxia-inducible factor prolyl hydroxylase activity.

Felix Oehme; Willi Jonghaus; Laila Narouz-Ott; Joachim Huetter; Ingo Flamme

Archive | 2006

Pharmaceutical dosage form based on an osmotic active ingredient release system comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin ii antagonist

Andreas Ohm; Klaus Benke; Hanna Tinel; Joachim Huetter

Archive | 2006

Diarylurinstoffer til behandling af pulmonær hypertension

Peter Sandner; Hanna Tinel; Joachim Huetter; Bernd Riedl; Ralph T. Schermuly; Friedrich Grimminger; Martina Klein

Archive | 2006

Inhibiteurs pde et combinaisons de ceux-ci pour traiter des troubles urinaires

Joachim Huetter; Peter Sandner; Hanna Tinel; Ernst Ulbrich

Archive | 2006

Diarylureas for treatment of pulmonary hypertension

Peter Sandner; Hanna Tinel; Joachim Huetter; Bernd Riedl; Martina Klein; Ralph T. Schermuly; Friedrich Grimminger

Archive | 2006

Diarylurinstoffer for the treatment of pulmonary hypertension

Peter Sandner; Hanna Tinel; Joachim Huetter; Bernd Riedl; Ralph T. Schermuly; Friedrich Grimminger; Martina Klein

Archive | 2006

Diarylharnstoffe zur behandlung von pulmonaler hypertonie Diaryl ureas for the treatment of pulmonary hypertension

Peter Sandner; Hanna Tinel; Joachim Huetter; Bernd Riedl; Martina Klein; Ralph T. Schermuly; Friedrich Grimminger

Archive | 2006

Diaryle-urees permettant de traiter l'hypertension pulmonaire

Peter Sandner; Hanna Tinel; Joachim Huetter; Bernd Riedl; Martina Klein; Ralph T. Schermuly; Friedrich Grimminger

Archive | 2006

Forme dosifiee pharmaceutique contenant une association de principes actifs de nifedipine et/ou de nisoldipine et un antagoniste de l'angiotensine-ii

Andreas Ohm; Klaus Benke; Hanna Tinel; Joachim Huetter

Explore More

Collaboration

Dive into the Joachim Huetter's collaboration.

Top Co-Authors
Avatar

Hanna Tinel

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Peter Sandner

Bayer

View shared research outputs
Top Co-Authors
Avatar

Martina Klein

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Bernd Riedl

Bayer

View shared research outputs
Top Co-Authors
Avatar

Ralph T. Schermuly

University of Giessen

View shared research outputs
Top Co-Authors
Avatar

Friedrich Grimminger

Imperial College London

View shared research outputs
Top Co-Authors
Avatar

Andreas Ohm

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Klaus Benke

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Barbara Albrecht

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Beatrix Stelte-Ludwig

Bayer Corporation

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge